Sexual health telehealth
Who prescribes ED medication online, and what the cheap chewables actually are.
11 providers offer this. 2 include labs in the price. 1 accept insurance. Figures reflect what each provider publishes. * = provisional score.
Highest-scored providers
#1 
Ro 9.0 
Blokes 6.3
Ro 9.0 Adults who want brand-name, FDA-approved GLP-1s with transparent cash pricing or help using commercial insurance, and who are comfortable with an online, message-based model.
Read the review → #2 Blokes 6.3 Men in one of the 34 eligible states who are willing to prepay several months of TRT to get a lower monthly price that includes medication and follow-up labs.
Read the review → #3 Male Excel 8.2*Men outside the 11 excluded states who want online TRT with an at-home starting test and are fine paying a monthly membership plus medication out of pocket.
Read the review →Ranked guides
All providers
| Clinic | Score | Consult | Labs | Prescriber | Insurance | From |
|---|---|---|---|---|---|---|
| Ro Also offers A large direct-to-consumer telehealth company whose Ro Body programme prescribes branded GLP-1 medication, alongside its ED and hair-loss lines. | 9.0 | Async | Included | MD/DO + NP/PA | Yes | $39 first month membership |
| Blokes Also offers A men’s telehealth clinic offering TRT, peptide therapy, GLP-1 weight loss and sexual health, with a sister brand for women. | 6.3 | Hybrid | Extra | MD/DO + NP/PA | Cash | $99/mo TRT on a 12-month plan |
| Male Excel Also offers A men’s telehealth provider offering TRT, ED treatment and weight loss with at-home testing. | 8.2* | — | Included | — | Cash | $99/mo membership |
| Rex MD A men’s telehealth provider offering ED medication, TRT and weight-loss treatment. | 7.6* | Async | n/a | — | Cash | $2/dose |
 Defy Medical Also offers One of the longest-running hormone telehealth clinics, offering TRT, HRT for women, peptide therapy and sexual health treatments with physician oversight. | 6.9* | Video | Extra | MD/DO + NP/PA | Cash | Under $175/mo average for TRT in year one |
 Maximus Also offers A men’s health telehealth brand offering TRT and enclomiphene protocols, a GLP-1 weight-loss programme, and hair and sexual health products. | 6.8* | Hybrid | Extra | MD/DO | — | $99.99/mo |
| Hims & Hers Also offers A publicly traded direct-to-consumer telehealth company offering weight-loss, sexual health, hair-loss and mental health treatment through an asynchronous model. | 6.7* | Async | Extra | MD/DO + NP/PA | Cash | $39 first month membership |
 Opt Health Also offers A men’s preventive-health telehealth provider combining comprehensive bloodwork with TRT and sexual health treatment under a physician. | 5.4* | Video | Extra | MD/DO + NP/PA | Cash | $95/mo |
 Craft Medical Also offers A TRT telehealth clinic with physician consults and a subscription that includes medication. | 4.6* | Video | — | — | — | $99 lab order to start |
 BlueChew An ED telehealth brand known for chewable compounded sildenafil and tadalafil. | Not scored | Async | n/a | — | — | — |
 Gameday Men’s Health Also offers A franchise network of men’s health clinics offering TRT, weight loss and ED treatment, with in-clinic visits and some telehealth follow-up. | Not scored | — | — | MD/DO + NP/PA | Cash | $199/mo |
Head-to-head comparisons
Tools for this decision
What these clinics prescribe
Reference records for the compounds offered in this category. Mechanism, dosing ranges, evidence level and regulatory status for each.
- hCG — A placental glycoprotein hormone that mimics LH directly at the testis, the long-standing standard for preserving fertility on TRT.
- PT-141 — A melanocortin-4 selective agonist approved for hypoactive sexual desire disorder, acting centrally rather than vascularly.
- Semaglutide — A long-acting GLP-1 receptor agonist and the compound that reset expectations for pharmacological weight loss.
- Sermorelin — The first 29 amino acids of endogenous growth-hormone-releasing hormone, and the shortest fragment that retains full biological activity.
- Tirzepatide — A dual GIP and GLP-1 receptor agonist that produced greater weight loss than semaglutide in head-to-head trial data.
References
Regulatory and primary sources
- American Urological Association clinical guidelines ↗ · includes the erectile dysfunction guideline
- HHS: Telehealth for patients ↗ · what to expect from a telehealth visit
- FDA: BeSafeRx, buying medicine online safely ↗ · how to check an online pharmacy
- NABP: Safe.Pharmacy verified websites ↗ · pharmacy accreditation lookup
- FSMB DocInfo: physician license lookup ↗ · check a prescriber is licensed
- FTC: Endorsements, influencers and reviews ↗ · disclosure rules for affiliate links
Published literature
- Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.Int Urol Nephrol 2017.PubMed 28741090 · doi:10.1007/s11255-017-1644-5
- Efficacy of L-arginine and Pycnogenol ® in the treatment of male erectile dysfunction: a systematic review and meta-analysis.Front Endocrinol (Lausanne) 2023.PubMed 37908749 · doi:10.3389/fendo.2023.1211720
- Apomorphine for the Treatment of Erectile Dysfunction: Systematic Review and Meta-Analysis.Arch Sex Behav 2020.PubMed 32964351 · doi:10.1007/s10508-020-01817-5
- The safety and efficacy of phosphodiesterase type 5 inhibitors in the treatment of diabetic erectile dysfunction: a systematic review and meta-analysis.PeerJ 2025.PubMed 41081100 · doi:10.7717/peerj.20147
- Efficacy and safety of on-demand dapoxetine combined with phosphodiesterase-5 inhibitor compared to monotherapy dapoxetine as a treatment of premature ejaculation without erectile dysfunction: a systematic review and meta-analysis.Arch Ital Urol Androl 2025.PubMed 41031773 · doi:10.4081/aiua.2025.14117
- Vardenafil in the Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis.Adv Ther 2021.PubMed 33432539 · doi:10.1007/s12325-020-01559-9
- Discontinuation Rates of Tadalafil Alone and in Combination with a-Blockers in the Treatment of Male Lower Urinary Tract Symptoms with or without Coexisting Erectile Dysfunction: A Systematic Review and Meta-Analysis.Int J Clin Pract 2022.PubMed 36419863 · doi:10.1155/2022/9298483
- Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis.Eur Urol 2015.PubMed 25817916 · doi:10.1016/j.eururo.2015.03.031
Literature retrieved from PubMed on October 18, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.